MorphoSys AG buy Mori8
Start price
15.06.21
/
50%
€64.56
Target price
15.06.22
-
Performance (%)
2.17%
End price
21.06.21
€65.96
Summary
This prediction ended on 21.06.21 with a price of €65.96. The BUY prediction by Mori8 finished with a performance of 2.17%. Mori8 has 50% into this predictionMorphoSys is a German biopharmaceutical company that develops innovative therapies for the treatment of cancer, autoimmune diseases, and other serious illnesses. The company specializes in developing monoclonal antibodies, which are highly specific and targeted therapies that recognize and bind to specific cancer cells or disease-causing proteins in the body. MorphoSys has a diverse pipeline of products in various stages of development, including several drugs that have shown promising results in clinical trials. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of over $4 billion.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| MorphoSys AG | 0.442% | 0.442% | 198.207% |
| iShares Core DAX® | -0.268% | 5.471% | 14.271% |
| iShares Nasdaq 100 | 1.854% | 7.851% | 35.426% |
| iShares Nikkei 225® | 0.284% | 1.729% | 9.943% |
| iShares S&P 500 | 1.178% | 5.269% | 27.989% |
Comments by Mori8 for this prediction
In the thread Morphosys AG diskutieren
Buy MorphoSys AG